La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Poly Medicure Bilan de santé
Santé financière contrôle des critères 6/6
Poly Medicure possède un total de capitaux propres de ₹14.7B et une dette totale de ₹1.7B, ce qui porte son ratio d'endettement à 11.8%. Son actif total et son passif total sont ₹18.6B et de ₹3.9B. L'EBIT de Poly Medicure est ₹3.1B ce qui fait que son ratio de couverture des intérêts 25.6. Elle dispose de liquidités et de placements à court terme de ₹2.9B.
Informations clés
11.8%
Ratio d'endettement
₹1.74b
Dette
| Ratio de couverture des intérêts | 25.6x |
| Argent liquide | ₹2.86b |
| Fonds propres | ₹14.70b |
| Total du passif | ₹3.89b |
| Total des actifs | ₹18.59b |
Mises à jour récentes de la santé financière
Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16Analyse de la situation financière
Passif à court terme: Les actifs à court terme de POLYMED ( ₹8.4B ) dépassent ses passifs à court terme ( ₹3.5B ).
Passif à long terme: Les actifs à court terme de POLYMED ( ₹8.4B ) dépassent ses passifs à long terme ( ₹373.8M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: POLYMED dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de POLYMED a été réduit de 35.9% à 11.8% au cours des 5 dernières années.
Couverture de la dette: La dette de POLYMED est bien couverte par le flux de trésorerie opérationnel ( 152.8% ).
Couverture des intérêts: Les paiements d'intérêts de POLYMED sur sa dette sont bien couverts par l'EBIT ( 25.6 x couverture).